Long-term Comparative Efficacy and Safety of Nivolumab Plus Ipilimumab Relative to Other First-Line Therapies for Advanced Non-Small-cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis
Lung cancer (Amsterdam, Netherlands)（2023）
Key words
Advanced lung cancer,Network meta-analysis,Overall survival,Progression-free survival,Immunotherapies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined